Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer

J Clin Oncol. 2008 Sep 1;26(25):4205-7. doi: 10.1200/JCO.2008.16.3709.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • DNA Mutational Analysis
  • ErbB Receptors / genetics
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lymphatic Metastasis
  • Neoadjuvant Therapy / methods*
  • Positron-Emission Tomography
  • Protein Kinase Inhibitors / administration & dosage*
  • Quinazolines / administration & dosage*
  • Remission Induction
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors